PIOGLITAZONA/METFORMIN FLOMI 15 mg/850 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

pioglitazona/metformin flomi 15 mg/850 mg

genepharm s.a. - grecia - combinatii ( pioglitazonum + metforminum) - compr. film. - 15mg/850mg - analogi ai glp-1 combinatii de antidiabetice orale

PIOGLITAZONA/METFORMIN FLOMI 15 mg/850 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

pioglitazona/metformin flomi 15 mg/850 mg

genepharm s.a. - grecia - combinatii (pioglitazonum + metforminum) - compr. film. - 15mg/850mg - analogi ai glp-1 combinatii de antidiabetice orale

Sitagliptin / Metformin hydrochloride Mylan Uniunea Europeană - română - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapie triplă) ca adjuvant la dietă și exercițiu fizic, la pacienți controlați inadecvat cu doza maximă tolerată de metformin și o sulfoniluree. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Sitagliptin / Metformin hydrochloride Sun Uniunea Europeană - română - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , terapie triplă) ca adjuvant la dietă și exercițiu fizic, la pacienți controlați inadecvat cu doza maximă tolerată de metformin și o sulfoniluree. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

METFORMIN ACCORD 500 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

metformin accord 500 mg

accord healthcare limited - metforminum - compr. elib. prel. - 500mg - antidiabetice orale si parenterale, exclusiv insuline biguanide

SITAGLIPTIN/CLORHIDRAT DE METFORMIN PHARMAZAC 50 mg/1000 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sitagliptin/clorhidrat de metformin pharmazac 50 mg/1000 mg

remedica ltd. - cipru - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/1000mg - analogi ai glp-1 combinatii de antidiabetice orale

SITAGLIPTIN/CLORHIDRAT DE METFORMIN PHARMAZAC 50 mg/850 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sitagliptin/clorhidrat de metformin pharmazac 50 mg/850 mg

remedica ltd. - cipru - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/850mg - analogi ai glp-1 combinatii de antidiabetice orale

METFORMIN MEDREG 1000 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

metformin medreg 1000 mg

zentiva s.a. - romania - metforminum - compr. film. - 1000mg - antidiabetice orale si parenterale, exclusiv insuline biguanide

METFORMIN MEDREG 500 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

metformin medreg 500 mg

zentiva s.a. - romania - metforminum - compr. film. - 500mg - antidiabetice orale si parenterale, exclusiv insuline biguanide

METFORMIN MEDREG 850 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

metformin medreg 850 mg

zentiva s.a. - romania - metforminum - compr. film. - 850mg - antidiabetice orale si parenterale, exclusiv insuline biguanide